KEROS THERAPEUTICS INC
KROS · NASDAQ
更新於 2026-10-14 12:55:34
$11.23-3.27%
- 今日最高
- $11.69
- 今日最低
- $11.19
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $11.77
- 昨天收盤價
- $11.61
- 成交量
- 223.67K
- 市值
- $230.19M
- 市盈率（P/E）
- --
- 每股收益（EPS）
- $-3.70
昨天價格區間
$11.58$12.08
52週價格區間
$9.69$22.55
公司概況
- 板塊
- 醫療保健
- 行業
- 生物科技
- 子行業
- 生物科技
- 總部
- 1050 WALTHAM STREET, LEXINGTON, MA, UNITED STATES, 02421
- 國家
- 美國
- 上市日期
- 2020-04-08
- 財年截止
- 十二月
- 流通股數
- 19.79M
- CIK
- 0001664710
- 官方網址
- www.kerostx.com
Keros Therapeutics, Inc. 是一家臨床階段生物製藥公司，專注於發現、開發及商業化針對血液學及肌肉骨骼疾病患者的新型療法，這些患者有巨大的未滿足醫療需求。公司總部位於麻薩諸塞州列星頓。
財務指標
營業收入
2026-06-30
$18.16M
2026-03-31
$367K
2025-12-31
$385K
2025-09-30
$14.26M
營業支出
2026-06-30
$30.93M
2026-03-31
$25.84M
2025-12-31
$29.65M
2025-09-30
$29.25M
淨利潤
2026-06-30
-$28.71M
2026-03-31
-$23.7M
2025-12-31
-$23.46M
2025-09-30
-$7.28M
淨利潤率
2026-06-30
-158.02%
2026-03-31
-6.45K%
2025-12-31
-6.09K%
2025-09-30
-51.04%
每股收益
2026-06-30
$-1.45
2026-03-31
$-1.21
2025-12-31
$-0.86
2025-09-30
$-0.18
息稅折舊攤銷前利潤
2026-06-30
-$28.3M
2026-03-31
-$23.3M
2025-12-31
-$24.57M
2025-09-30
-$8.3M
有效稅率
2026-06-30
-7.73%
2026-03-31
--
2025-12-31
6.06%
2025-09-30
16.36%
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $18.16M | $367K | $385K | $14.26M |
| 營業支出 | $30.93M | $25.84M | $29.65M | $29.25M |
| 淨利潤 | -$28.71M | -$23.7M | -$23.46M | -$7.28M |
| 淨利潤率 | -158.02% | -6.45K% | -6.09K% | -51.04% |
| 每股收益 | $-1.45 | $-1.21 | $-0.86 | $-0.18 |
| 息稅折舊攤銷前利潤 | -$28.3M | -$23.3M | -$24.57M | -$8.3M |
| 有效稅率 | -7.73% | -- | 6.06% | 16.36% |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。